World-renowned cancer oncologist, health consultant and

World-renowned cancer oncologist, health consultant and

Dr. Teich received his degree in medicine from Rio de Janeiro State University (UERJ), and had his training in Oncology at the Brazilian National Cancer Institute. He has an MBA in health administration at the Institute for Postgraduate Studies and Research in Administration at the Federal University of Rio de Janeiro. He also holds a master’s degree in economic assessment from the University of York in UK and had his education in Management and Entrepreneurship at Harvard Business School. Dr. Teich joins an esteemed team of scientists, clinicians and management from world-leading research institutions, including Dr. Craig A. Bunnell, MD, MPH, MBA – Dana-Farber Cancer Institute, Jennifer Levin Carter, MD, MPH, MBA – JLC Precision Health Strategies, LLC., Barry Fogel M.D. – Harvard School of Medicine, Professor Donald Lessard – MIT Sloan School of Management, and Judy C. Lewent – Former Executive Vice President & Chief Financial Officer, Merck & Co. 4D Path BoilerplateJust because you can’t see something, doesn’t mean it’s not there. 4D Path’s patented precision oncology platform is designed to unveil previously hidden data to instantly provide biomarker profiling and stratification directly from H&E whole slide biopsy/resection images only. 4D Path’s cloud-based, quantitative approach is intended to eliminate the need for additional molecular tests (e.g., immunohistochemistry, FISH, RNA-Seq, NGS), accelerating complete, actionable and objective insight leading to expedited and democratized precision medicine. 4D Path’s quantitative approach is designed to provide clinical solutions in both companion diagnostics and translational medicine without compromising the current standard of care to reduce the cost, time and complexity of patient care and management, and clinical trials. Its patented methods and integrated platform combine universal physics, biology, and mathematical principles to identify tumor-specific phenotypic and genotypic fingerprints in order to inform treatment selection and stratify patients accordingly. Visit www.4dpath.com to learn more.

Prior to his service to the Brazilian Ministry of Health, Teich founded and acted as president of GRUPO Clinical Oncology Group (COI). At his helm, COI became the largest company in Brazil in its segment, and he established the COI Management, Education and Research Institute as one of the main cancer research institutes in Brazil. The non-profit COI Management, Education and Research Institute enables randomized controlled clinical trials and observational prospective real-world studies, as well as training and education programs in many different areas of cancer care, including hematology, oncology, radiotherapy, radiation physics, nursing, and pharmacy, among others. Awarded FDA Breakthrough Device Designation, 4D Path applies its cloud-based, quantitative approach to finding the data previously hidden in H&E biopsy and resection images without adding extra load to the current standard of care. In near real time, 4D Path can identify cancer type, its grade, and its pan-cancer prognostically significant molecular subtypes, just from whole slide H&E biopsy/resection images. As a result, the initial biopsy may no longer be the first step in a lengthy process towards biomarker profiling and stratification, but perhaps the only step necessary without the need for additional molecular tests (e.g., immunohistochemistry, FISH, NGS).

“We are pleased to add a clinical oncology leader of Nelson’s caliber to our advisory board,” said Rodrigo Navarro, president and CEO, 4D Path. “His expertise in facilitating clinical research and supporting innovative, evidence-based health technologies make him an ideal partner for moving 4D Path’s cancer diagnostic and precision oncology platform technology to the next stage and expanding our reach worldwide to the full spectrum of cancer malignancies for more readily accessible and affordable care.” “My extensive career in oncology has exposed me to the true impact that technology can have on the fight against cancer, which is why the revolutionary nature of 4D Path’s technology truly caught my attention,” said Dr. Teich. “Different countries have different problems, inefficiencies and needs that have to be solved for them to deliver the ideal cancer care. High quality cancer care depends on and starts with a precise, detailed, and fast diagnostic process. Real evolution of health care systems happens when accuracy, precision and complexity of diagnostic and therapeutic procedures are improved and at the same time processes and flows are simplified. 4D Path brings this evolution to cancer care, by bringing solutions that improve the efficiency of the system and it shows a rare combination of increasing precision and accuracy, simplifying processes, improving outcomes, and reducing costs. This is a perfect example of a solution that brings value to the health care system. 4D Path solutions can be customized to the realities that exist in different countries, systems and providers.”

Source

The News Highlights

  • World-renowned cancer oncologist, health consultant and
  • Check the latest Health news updates and information about health.
Disclaimer: If you need to edit or update this news from compsmag then kindly contact us Learn more

For Latest News Follow us on Google News


Latest Headlines
  • Show all
  • Trending News
  • Popular By week
Immunome Reports First Quarter 2021 Financial Results

Immunome Reports First Quarter 2021 Financial Results

Financial Highlights “I am thrilled with the significant progress that Immunome has made in the development of our product pipeline,” said Purnanand Sarma, ...
Students must create university health program in project led by UMaine – News from UMaine

Students must create university health program in project led by UMaine – News from UMaine

McNamara says three students from each university will then form a steering committee with health professionals and administrators and participate in a ...
Watch a live demo of Distant Worlds 2, an upcoming space 4X game

Watch a live demo of Distant Worlds 2, an upcoming space 4X game

The sequel is due out later this year, but while we wait to hear more you can at least satisfy your curiosity with some live gameplay. During publisher ...
U.S. Medical Cannabis Market Projected to Almost Double to

U.S. Medical Cannabis Market Projected to Almost Double to

News HighlightsWashington, May 11, 2021 (News) — New Frontier Data (https://NewFrontierData.com), the global authority in data, analytics and business ...
Returning to large crowds can affect mental health, says psychologist |  Berks Regional News

Returning to large crowds can affect mental health, says psychologist | Berks Regional News

“Expect that there’s going to be an adjustment period,” advised Ring. “And don’t have expectations that are excessive. That you’re going to go through this ...
According to records, Epic wanted Sony’s PlayStation PC games to compete with Steam

According to records, Epic wanted Sony’s PlayStation PC games to compete with Steam

A 222-page confidential document, filed as part of the Epic v. Apple trial, reveals a broad effort to compete with Steam during 2020 with free ...
How can you get extra money to pay your monthly internet bill

How can you get extra money to pay your monthly internet bill

Source www.wtnh.com You could qualify if you use SNAP, Medicaid, or other Lifeline benefits. Also, if your child gets free or reduced lunch or if you lost a ...
Bradley Beal will miss two games and will be evaluated again on Friday

Bradley Beal will miss two games and will be evaluated again on Friday

Beal’s next chance to return to the lineup will come Friday against the Cleveland Cavaliers. That is the second-to-last game of the season for the Wizards, ...
Apple Rumors swing Around Lucid Motors and the reason behind CCIV’s Stock Is the Next Tesla?

Apple Car Is back in the news, Rumors suggest New Partners

LG Magna e-Powertrain – the joint venture between Magna International and LG is now in infancy, but after necessary approvals, it should be final by ...
Show next
Compsmag - Latest News from tech, business and health
Logo